Veterinary medicines European public assessment report (EPAR): Varenzin, molidustat, Status: Authorised

Human medicines European public assessment report (EPAR): Heplisav B, hepatitis B surface antigen, Date of authorisation: 18/02/2021, Revision: 8, Status: Authorised

Human medicines European public assessment report (EPAR): Biktarvy, bictegravir,emtricitabine,tenofovir alafenamide, Date of authorisation: 21/06/2018, Revision: 19, Status: Authorised

Emerging safety issues (ESI) contact points at the national competent authority (NCA) level

HMA-EMA Network Data Steering Group: membership list

HMA-EMA joint Network Data Steering Group meeting - 8 December 2025

Minutes of the HMPC meeting 17-19 November 2025

Questions and answers on Implementing Regulation (EU) 2025/1466: Amendment of Regulation (EU) No 520/2012 and Conclusion of the Signal Detection in EudraVigilance Pilot by marketing authorisation holders

Questions and answers on how to use a CEP in the context of a Marketing Authorisation Application or a Marketing Authorisation Variation

ICH Q3E Extractables and leachables - scientific guideline